List of insiders holdings for HERON THERAPEUTICS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD 10% Owner |
2014-02-14 16:32:42 | 35,248,555 0 |
35,248,555 | Form 13G |
| 2 | Rubric Capital Management LP Rosen David Efraim 10% Owner |
2024-05-31 11:08:56 | 26,713,503 0 |
26,713,503 | Form 13D |
| 3 | Baker / Tisch Capital (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
2011-07-06 17:59:45 | 20,526,568 0 |
20,526,568 | Form 13D |
| 4 | Baker Biotech Capital (GP) LLC BAKER FELIX BAKER JULIAN 10% Owner |
2011-07-06 17:59:45 | 20,526,568 0 |
20,526,568 | Form 13D |
| 5 | Baker Brothers Life Sciences Capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner |
2011-07-06 17:59:45 | 20,526,568 0 |
20,526,568 | Form 13D |
| 6 | 14159 capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner |
2011-07-06 17:59:45 | 20,526,568 0 |
20,526,568 | Form 13D |
| 7 | Baker Bros. Capital (GP) LLC BAKER JULIAN BAKER FELIX 10% Owner |
2011-07-06 17:59:45 | 20,526,568 0 |
20,526,568 | Form 13D |
| 8 | Morgan Adam Director |
2025-02-04 17:37:16 | 105,677 6,986,744 |
7,092,421 | Form 4/A |
| 9 | BARR JOHN Vice President of R&D |
2011-07-12 17:23:46 | 7,000,000 0 |
7,000,000 | Form 4 |
| 10 | Velan Capital Investment Management LP Velan Capital Master Fund LP Velan Capital Holdings LLC Velan Capital Management LLC VENKATARAMAN BALAJI Morgan Adam See Footnote 2 |
2023-02-08 18:26:00 | 0 4,500,000 |
4,500,000 | Form 3 |
| 11 | TANG KEVIN C TANG CAPITAL MANAGEMENT LLC TANG CAPITAL PARTNERS LP Director 10% Owner |
2023-02-14 16:00:28 | 3,756,694 0 |
3,756,694 | Form 13G |
| 12 | ADAM MICHAEL A Chief Operating Officer |
2013-02-12 20:34:35 | 1,000,000 0 |
1,000,000 | Form 4 |
| 13 | Quart Barry D Chief Executive Officer |
2023-01-20 17:10:01 | 850,000 0 |
850,000 | Form 4 |
| 14 | KOTLER KEVIN Director |
2023-03-02 16:13:38 | 265,151 540,000 |
805,151 | Form 3 |
| 15 | Savitr Capital LLC Exiting 10% holder |
2016-01-28 17:08:48 | 772,000 0 |
772,000 | Form 13G |
| 16 | SPCH LLC Midler Andrew R Exiting 10% holder |
2016-01-28 17:09:23 | 772,000 0 |
772,000 | Form 13G |
| 17 | Whelan John CFO |
2013-07-19 19:21:59 | 647,454 0 |
647,454 | Form 4 |
| 18 | Duarte Ira EVP, Chief Financial Officer |
2025-02-04 12:44:10 | 561,330 0 |
561,330 | Form 4 |
| 19 | Forbes William P EVP, Chief Development Officer |
2025-02-04 12:44:33 | 561,330 0 |
561,330 | Form 4 |
| 20 | Collard Craig A Chief Executive Officer |
2025-04-03 17:48:40 | 502,367 0 |
502,367 | Form 4 |
| 21 | TURNBULL GREG Director |
2012-05-31 14:09:23 | 500,000 0 |
500,000 | Form 4 |
| 22 | GODDARD PAUL Chairman |
2012-05-31 14:11:39 | 500,000 0 |
500,000 | Form 4 |
| 23 | Rosen Robert President |
2018-12-18 20:09:58 | 300,000 0 |
300,000 | Form 4 |
| 24 | PRENTKI RONALD J President & CEO |
2010-02-19 13:27:23 | 250,000 0 |
250,000 | Form 4 |
| 25 | ROSENBLATT TOBY Director |
2010-05-26 13:55:15 | 210,234 0 |
210,234 | Form 4 |
| 26 | ZERBE ROBERT L MD Director |
2010-05-26 13:56:04 | 202,072 0 |
202,072 | Form 4 |
| 27 | Clendeninn Neil James SVP & Chief Medical Officer |
2015-10-13 21:21:46 | 150,000 0 |
150,000 | Form 4 |
| 28 | DAVIS STEPHEN Director |
2022-12-20 17:19:23 | 129,192 0 |
129,192 | Form 4 |
| 29 | Dissanaike Sharmila Director |
2025-02-04 17:34:12 | 123,080 0 |
123,080 | Form 4/A |
| 30 | Rodriguez Susan Director |
2025-02-04 17:27:22 | 123,080 0 |
123,080 | Form 4/A |
| 31 | Christian Waage Director |
2025-02-04 17:23:44 | 120,030 0 |
120,030 | Form 4/A |
| 32 | Johnson Craig A Director |
2025-02-04 17:30:25 | 119,670 0 |
119,670 | Form 4/A |
| 33 | Retzios Anastassios D. VP of Clinical Development |
2008-01-17 21:47:32 | 114,700 0 |
114,700 | Form 4 |
| 34 | HOFFMAN ROBERT CFO & SVP, Finance |
2019-12-23 16:28:00 | 100,000 0 |
100,000 | Form 4 |
| 35 | RIEPENHAUSEN PETER Director |
2008-05-30 18:16:46 | 51,567 44,833 |
96,400 | Form 4 |
| 36 | Kaseta Michael Director |
2025-02-04 17:40:31 | 91,729 0 |
91,729 | Form 4/A |
| 37 | DRURY STEPHEN A Director |
2006-08-14 14:38:27 | 1,429 84,712 |
86,141 | Form 4 |
| 38 | POYHONEN JOHN President & CCO |
2023-04-17 17:27:57 | 82,084 0 |
82,084 | Form 4 |
| 39 | WINGER DENNIS L Director |
2006-08-14 14:40:09 | 69,544 0 |
69,544 | Form 4 |
| 40 | MANHARD KIMBERLY EVP, Drug Development |
2023-04-17 17:26:14 | 63,766 0 |
63,766 | Form 4 |
| 41 | Szekeres David Leslie EVP, Chief Operating Officer |
2023-07-17 17:51:53 | 63,376 0 |
63,376 | Form 4 |
| 42 | Peraza Lisa VP, Chief Accounting Officer |
2024-01-19 21:01:56 | 47,924 0 |
47,924 | Form 4 |
| 43 | Gelder Mark S. MD SVP & Chief Medical Officer |
2014-12-15 20:59:55 | 45,000 0 |
45,000 | Form 4 |
| 44 | OCONNELL MICHAEL Chief Executive Officer |
2006-01-12 18:45:31 | 45,000 0 |
45,000 | Form 4 |
| 45 | Marshall Paul SVP, Technical Operations |
2016-03-23 15:07:10 | 45,000 0 |
45,000 | Form 4 |
| 46 | TAYLOR ARTHUR T Director |
2008-05-30 19:14:02 | 35,750 0 |
35,750 | Form 4 |
| 47 | WHITEFORD STEPHEN V.P., Finance & CFO |
2006-12-18 18:15:32 | 15,000 0 |
15,000 | Form 4 |
| 48 | Drazba Brian G. VP, Finance & CFO |
2016-12-23 16:03:07 | 4,913 0 |
4,913 | Form 4 |
| 49 | TANG KEVIN C Former Director Director |
2021-02-16 16:18:45 | 0 3,445 |
3,445 | Form 5 |